🔎 Trials Near Me

Beranda › Kanker Ginjal (Karsinoma Sel Renal) › California › San Diego

Uji klinis Kanker Ginjal (Karsinoma Sel Renal) di San Diego, CA

14 studi untuk Kanker Ginjal (Karsinoma Sel Renal) mencari peserta di lokasi sekitar San Diego (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Menerima pesertaFase 1
  • Research Site, San Diego
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT05536141

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Menerima pesertaFase 1
  • NEO-811 San Diego Site, San Diego
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07300241

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Menerima pesertaFase 1
  • University of California San Diego Moores Cancer Center, La Jolla · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06234605

DESTINY-PANTUMOUR04

Menerima pesertaStudi observasional
  • Research Site, San Diego
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07124000

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Menerima pesertaStudi observasional
  • University of California San Diego, La Jolla · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04981119

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

Menerima pesertaFase 2
  • University of California San Diego, La Jolla · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06863311

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Menerima pesertaFase 2
  • UC San Diego Medical Center - Hillcrest, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Menerima pesertaFase 1/2
  • UC San Diego Medical Center - Bankers Hill, San Diego
  • UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
  • UC San Diego Medical Center - Hillcrest, San Diego
  • dan 5 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07227415

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Menerima pesertaFase 1
  • University of California San Diego Medical Center, Moores Cancer Center, La Jolla · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07195916

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Menerima pesertaStudi observasional
  • University of California, San Diego, La Jolla · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05059444

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Menerima pesertaFase 3
  • UC San Diego Medical Center - Hillcrest, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06661720

Retifanlimab and Ruxolitinib In Solid Malignancies

Menerima pesertaFase 1/2
  • University of California, San Diego Moores Cancer Center, La Jolla · 11 mi jauhnya
Semua usia · Semua jenis kelamin · Diperbarui 13 Jan 2026 · NCT07219576

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Menerima pesertaFase 1/2
  • UCSD Moores Cancer Center, La Jolla · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2025 · NCT06682793

A Beta-only IL-2 ImmunoTherapY Study

Menerima pesertaFase 1/2
  • Sharp Memorial Hospital, San Diego
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jul 2025 · NCT05086692

Uji klinis Kanker Ginjal (Karsinoma Sel Renal) di kota lain

Studi lain di San Diego

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.